Variant report

Variant	nsv897590
Chromosome Location	chr11:58803828-58846985
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr11:58831402-58832419	GM12878	blood:	n/a	n/a
2	ATF2	chr11:58831671-58832143	GM12878	blood:	n/a	n/a
3	ATF2	chr11:58825833-58826405	GM12878	blood:	n/a	n/a
4	BACH1	chr11:58825972-58826213	H1-hESC	embryonic stem cell:	n/a	n/a
5	BATF	chr11:58831471-58831776	GM12878	blood:	n/a	n/a
6	BATF	chr11:58826199-58826498	GM12878	blood:	n/a	n/a
7	BATF	chr11:58818940-58819193	GM12878	blood:	n/a	n/a
8	BATF	chr11:58831416-58832275	GM12878	blood:	n/a	chr11:58831926-58831934
9	BATF	chr11:58831786-58832150	GM12878	blood:	n/a	chr11:58831926-58831934
10	BCL11A	chr11:58831483-58831904	GM12878	blood:	n/a	n/a
11	BCL11A	chr11:58818899-58819262	GM12878	blood:	n/a	chr11:58819091-58819100
12	BCL11A	chr11:58818878-58819275	GM12878	blood:	n/a	chr11:58819091-58819100
13	BCL11A	chr11:58831528-58832157	GM12878	blood:	n/a	n/a
14	BCL3	chr11:58831794-58832281	GM12878	blood:	n/a	n/a
15	BHLHE40	chr11:58825938-58826278	GM12878	blood:	n/a	n/a
16	BHLHE40	chr11:58820953-58821000	K562	blood:	n/a	n/a
17	BHLHE40	chr11:58826040-58826162	K562	blood:	n/a	n/a
18	BRCA1	chr11:58825950-58826184	GM12878	blood:	n/a	n/a
19	CEBPB	chr11:58825987-58826187	H1-hESC	embryonic stem cell:	n/a	n/a
20	CEBPB	chr11:58835714-58835923	HepG2	liver:	n/a	chr11:58835780-58835791
21	CEBPB	chr11:58841369-58841519	IMR90	lung:	n/a	n/a
22	CEBPB	chr11:58835627-58835890	IMR90	lung:	n/a	chr11:58835780-58835791
23	CEBPB	chr11:58835676-58835875	K562	blood:	n/a	chr11:58835780-58835791
24	CEBPB	chr11:58827942-58827984	H1-hESC	embryonic stem cell:	n/a	n/a
25	CHD1	chr11:58821218-58821270	H1-hESC	embryonic stem cell:	n/a	n/a
26	CHD1	chr11:58825963-58826312	GM12878	blood:	n/a	n/a
27	CHD2	chr11:58826018-58826077	K562	blood:	n/a	n/a
28	CHD2	chr11:58825822-58826232	H1-hESC	embryonic stem cell:	n/a	n/a
29	CHD2	chr11:58825891-58826300	GM12878	blood:	n/a	n/a
30	CREB1	chr11:58845805-58846333	GM12878	blood:	n/a	n/a
31	CREB1	chr11:58845766-58846361	GM12878	blood:	n/a	n/a
32	CTCF	chr11:58820771-58821119	K562	blood:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
33	CTCF	chr11:58820920-58821070	Hela-S3	cervix:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
34	CTCF	chr11:58820878-58821091	H1-hESC	embryonic stem cell:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
35	CTCF	chr11:58825980-58826130	AG04449	skin:	n/a	n/a
36	CTCF	chr11:58811099-58811130	GM20000	blood:	n/a	n/a
37	CTCF	chr11:58826286-58826352	GM12892	blood:	n/a	n/a
38	CTCF	chr11:58820650-58820688	GM12878	blood:	n/a	n/a
39	CTCF	chr11:58820620-58820770	HRE	kidney:	n/a	n/a
40	CTCF	chr11:58826020-58826170	GM12875	blood:	n/a	n/a
41	CTCF	chr11:58820920-58821070	WI-38	lung:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
42	CTCF	chr11:58826020-58826170	HepG2	liver:	n/a	n/a
43	CTCF	chr11:58820642-58820718	GM10266	blood:	n/a	n/a
44	CTCF	chr11:58820846-58821117	H1-hESC	embryonic stem cell:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
45	CTCF	chr11:58820639-58820705	GM10248	blood:	n/a	n/a
46	CTCF	chr11:58820840-58820990	BJ	skin:	n/a	chr11:58820969-58820985 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
47	CTCF	chr11:58820826-58821122	Medullo	brain:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
48	CTCF	chr11:58820780-58821155	GM12878	blood:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
49	CTCF	chr11:58820920-58821070	NHLF	lung:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986
50	CTCF	chr11:58820860-58821010	HRPEpiC	eye:	n/a	chr11:58820969-58820985 chr11:58820970-58820991 chr11:58820971-58820980 chr11:58820971-58820984 chr11:58820968-58820986

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:58806952-58807002	HPAEpiC	pulmonary alveolar:	n/a
2	chr11:58830191-58830241	H1-hESC	embryonic stem cell:	embryo
3	chr11:58806952-58807002	HPAEpiC	pulmonary alveolar:	n/a
4	chr11:58830191-58830241	H1-hESC	embryonic stem cell:	embryo
5	chr11:58810187-58810237	HNPCEpiC	eye:	n/a
6	chr11:58826414-58826464	AoSMC	blood vessel:	n/a
7	chr11:58828174-58828224	HRCEpiC	kidney:	n/a
8	chr11:58825714-58825764	Hepatocyte	liver:	n/a
9	chr11:58826475-58826525	AG04449	skin:	fetal
10	chr11:58806952-58807002	HAEpiC	amniotic membrane:	n/a
11	chr11:58830424-58830474	MCF10A-Er-Src	breast:	n/a
12	chr11:58830355-58830405	Hela-S3	cervix:	n/a
13	chr11:58828174-58828224	HRPEpiC	eye:	n/a
14	chr11:58810187-58810237	GM06990	blood:	n/a
15	chr11:58830424-58830474	GM19239	blood:	n/a
16	chr11:58830424-58830474	HRPEpiC	eye:	n/a
17	chr11:58828174-58828224	A549	lung:	n/a
18	chr11:58826475-58826525	SAEC	small airway:	n/a
19	chr11:58825714-58825764	HCT-116	colon:	n/a
20	chr11:58825870-58825920	H1-hESC	embryonic stem cell:	embryo
21	chr11:58825714-58825764	HIPEpiC	eye:	n/a
22	chr11:58806952-58807002	ECC-1	luminal epithelium:	n/a
23	chr11:58826414-58826464	MCF-7	breast:	n/a
24	chr11:58833356-58833406	HCF	heart:	n/a
25	chr11:58830355-58830405	A549	lung:	n/a
26	chr11:58826414-58826464	A549	lung:	n/a
27	chr11:58825870-58825920	Jurkat	blood:	n/a
28	chr11:58826073-58826123	AG09319	gingival:	n/a
29	chr11:58830857-58830907	ECC-1	luminal epithelium:	n/a
30	chr11:58826110-58826160	SAEC	small airway:	n/a
31	chr11:58826414-58826464	HEK293	kidney:	embryo
32	chr11:58828174-58828224	AG04450	lung:	fetal
33	chr11:58830857-58830907	AG04450	lung:	fetal
34	chr11:58830424-58830474	HMEC	breast:	n/a
35	chr11:58806952-58807002	PrEC	prostate:	n/a
36	chr11:58810187-58810237	Caco-2	colon:	n/a
37	chr11:58830355-58830405	HL-60	blood:	n/a
38	chr11:58825714-58825764	Hela-S3	cervix:	n/a
39	chr11:58833356-58833406	SK-N-MC	brain:	n/a
40	chr11:58830857-58830907	HCT-116	colon:	n/a
41	chr11:58830857-58830907	RPTEC	kidney:	n/a
42	chr11:58826073-58826123	GM06990	blood:	n/a
43	chr11:58826475-58826525	SK-N-SH_RA	brain:	n/a
44	chr11:58825870-58825920	GM12891	blood:	n/a
45	chr11:58830610-58830660	PANC-1	pancreas:	n/a
46	chr11:58825870-58825920	SK-N-SH_RA	brain:	n/a
47	chr11:58825870-58825920	HNPCEpiC	eye:	n/a
48	chr11:58830191-58830241	K562	blood:	n/a
49	chr11:58830424-58830474	HCPEpiC	choroid plexus:	n/a
50	chr11:58825714-58825764	GM19239	blood:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:58830364..58831268-chr11:58873992..58874927,2	HCT-116	colon:
2	chr11:58399679..58402149-chr11:58838160..58840024,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GLYATL2-2	chr11:58825845-58825923	ENSG00000255240.1
2	lnc-GLYATL2-2	chr11:58825845-58825925	NR_033853
3	lnc-GLYATL2-2	chr11:58820930-58821099	NR_033853
4	lnc-GLYATL2-2	chr11:58820930-58821099	ENSG00000255240.1
5	lnc-GLYATL2-2	chr11:58820930-58821099	ENSG00000255240.1
6	lnc-GLYATL2-2	chr11:58825845-58826132	ENSG00000255240.1
7	lnc-GLYATL2-2	chr11:58818733-58818781	NR_033853
8	lnc-GLYATL2-2	chr11:58818733-58818781	ENSG00000255240.1
9	lnc-GLYATL2-2	chr11:58818733-58818781	ENSG00000255240.1
10	lnc-GLYATL2-2	chr11:58822768-58822919	ENSG00000255240.1

Variant related genes	Relation type
ENSG00000255240	TF binding region
GLYATL1P4	TF binding region
ENSG00000255240	CpG island
GLYATL1P4	CpG island
ENSG00000189057	chromatin interactions

Extended variants
information (count: 1540 )
Associated
traits (count: 53 )

Variant overlapped rSNPs/rCNVs (count:1540 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1061538	chr11:58803828-58803829	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs578258853	chr11:58803841-58803842	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs368304381	chr11:58803866-58803867	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs372357066	chr11:58803926-58803927	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs12364258	chr11:58803950-58803951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs535409241	chr11:58803982-58803983	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs555213786	chr11:58803985-58803986	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs143502770	chr11:58804031-58804032	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs115972895	chr11:58804040-58804041	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs72919117	chr11:58804042-58804043	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs375419352	chr11:58804089-58804090	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs541112370	chr11:58804093-58804094	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs4081462	chr11:58804098-58804099	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs3897648	chr11:58804100-58804101	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs559151890	chr11:58804140-58804141	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs2004519	chr11:58804162-58804163	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs548203887	chr11:58804173-58804174	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs11229762	chr11:58804174-58804175	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs112309578	chr11:58804176-58804177	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs534829447	chr11:58804245-58804246	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs530426836	chr11:58804320-58804321	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs552196708	chr11:58804402-58804403	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs116383938	chr11:58804403-58804404	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs193086314	chr11:58804410-58804411	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs138749863	chr11:58804411-58804412	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs1815851	chr11:58804427-58804428	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs1815850	chr11:58804430-58804431	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs546695251	chr11:58804473-58804474	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs28407281	chr11:58804476-58804477	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs577311502	chr11:58804535-58804536	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs536818998	chr11:58804536-58804537	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs185882040	chr11:58804554-58804555	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs545868924	chr11:58804575-58804576	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs576723558	chr11:58804629-58804630	Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs537337540	chr11:58804653-58804654	Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs189075305	chr11:58804688-58804689	Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs4938908	chr11:58804692-58804693	Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs541150921	chr11:58804726-58804727	Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs180964160	chr11:58804782-58804783	Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs574301767	chr11:58804793-58804794	Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs541961810	chr11:58804803-58804804	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs150764798	chr11:58804837-58804838	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs563334662	chr11:58804847-58804848	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs2004664	chr11:58804858-58804859	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs1815849	chr11:58804913-58804914	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs564097086	chr11:58804920-58804921	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs528061971	chr11:58804946-58804947	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs111888353	chr11:58804953-58804954	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs34151016	chr11:58804978-58804979	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs139156668	chr11:58805041-58805042	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:53)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Esophageal cancer	21851588	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Autism	22495309	CNVD
Autism	20808228	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:345 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:58782800-58810600	Weak transcription	Primary B cells from cord blood	blood
2	chr11:58803200-58804600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr11:58804400-58804600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr11:58804400-58804600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
5	chr11:58804600-58805000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr11:58804600-58806200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
7	chr11:58804600-58807400	Weak transcription	Primary B cells from peripheral blood	blood
8	chr11:58804800-58805000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr11:58804800-58805200	Enhancers	Primary hematopoietic stem cells	blood
10	chr11:58804800-58805200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr11:58805000-58805200	Enhancers	Rectal Mucosa Donor 31	rectum
12	chr11:58805000-58806200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr11:58805000-58825200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr11:58805200-58825400	Weak transcription	Primary hematopoietic stem cells	blood
15	chr11:58806200-58807400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr11:58806200-58807800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr11:58807400-58808000	Strong transcription	Primary B cells from peripheral blood	blood
18	chr11:58808000-58808200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr11:58808000-58808600	Enhancers	Stomach Mucosa	stomach
20	chr11:58808000-58810800	Weak transcription	Primary B cells from peripheral blood	blood
21	chr11:58810600-58811400	Strong transcription	Primary B cells from cord blood	blood
22	chr11:58810800-58811800	Strong transcription	Primary B cells from peripheral blood	blood
23	chr11:58811400-58818200	Weak transcription	Primary B cells from cord blood	blood
24	chr11:58811800-58816200	Weak transcription	Primary B cells from peripheral blood	blood
25	chr11:58813600-58825200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr11:58815400-58824400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
27	chr11:58816200-58818200	Strong transcription	Primary B cells from peripheral blood	blood
28	chr11:58816600-58816800	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr11:58816800-58817000	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr11:58817000-58817200	Enhancers	iPS-20b Cell Line	embryonic stem cell
31	chr11:58817000-58817200	Enhancers	Fetal Intestine Large	intestine
32	chr11:58817000-58818200	Weak transcription	HUES6 Cell Line	embryonic stem cell
33	chr11:58817200-58821800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
34	chr11:58817200-58825200	Weak transcription	Liver	Liver
35	chr11:58817200-58825400	Weak transcription	Fetal Intestine Large	intestine
36	chr11:58817400-58819400	Enhancers	iPS-18 Cell Line	embryonic stem cell
37	chr11:58817400-58822000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
38	chr11:58818200-58818600	Genic enhancers	Primary B cells from peripheral blood	blood
39	chr11:58818200-58819400	Enhancers	HUES6 Cell Line	embryonic stem cell
40	chr11:58818200-58820200	Enhancers	Primary B cells from cord blood	blood
41	chr11:58818600-58825200	Enhancers	Primary B cells from peripheral blood	blood
42	chr11:58818800-58819400	Enhancers	GM12878-XiMat	blood
43	chr11:58819200-58819400	Enhancers	HUES48 Cell Line	embryonic stem cell
44	chr11:58819400-58820600	Weak transcription	GM12878-XiMat	blood
45	chr11:58819400-58821200	Weak transcription	HUES48 Cell Line	embryonic stem cell
46	chr11:58819400-58822000	Weak transcription	HUES6 Cell Line	embryonic stem cell
47	chr11:58819400-58822600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
48	chr11:58820200-58820800	Weak transcription	Primary B cells from cord blood	blood
49	chr11:58820600-58821200	Enhancers	GM12878-XiMat	blood
50	chr11:58820800-58822200	Enhancers	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links